CanniMed Therapeutics Inc. (TSE:CMED – Get Free Report) shares fell 5.3% during trading on Monday . The company traded as low as C$27.00 and last traded at C$27.00. 52,208 shares changed hands during trading, a decline of 87% from the average session volume of 387,394 shares. The stock had previously closed at C$28.50.
CanniMed Therapeutics Price Performance
The business has a 50 day simple moving average of C$27.00.
CanniMed Therapeutics Company Profile
CanniMed Therapeutics Inc operates as a plant biopharmaceutical company that specializes in medical cannabis. The company cultivates and sells pharmaceutical-grade cannabis products in dried herbal and oil forms for Canadian patients. It also offers herbal cannabis and cannabis oil; and vaporizers, consumable vaporizer accessories, and herb mills.
Featured Stories
- Five stocks we like better than CanniMed Therapeutics
- Low PE Growth Stocks: Unlocking Investment Opportunities
- High-Yield Texas Instruments Could Hit New Highs Soon
- Bank Stocks – Best Bank Stocks to Invest In
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- How to Use the MarketBeat Stock Screener
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for CanniMed Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CanniMed Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
